Hypophosphatemia associated with use of intravenous ferric carboxymaltose

  1. Proaño Fierro, María Esther 1
  2. Rodríguez Cañete, Blanca Leticia 1
  3. Sánchez Sobrino, Paula 1
  4. Rego Iraeta, Antonia Lourdes 1
  1. 1 Complexo Hospitalario Universitario de Pontevedra
    info

    Complexo Hospitalario Universitario de Pontevedra

    Pontevedra, España

    ROR https://ror.org/016cxc226

Journal:
Nutrición Hospitalaria

ISSN: 1699-5198,  0212-1611

Year of publication: 2023

Volume: 40

Issue: 6

Pages: 1301-1304

Type: Article

DOI: 10.20960/NH.04806 GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Nutrición Hospitalaria

Sustainable development goals

Bibliographic References

  • Manual de Endocrinología y Nutrición. (s/f). Seen.es. Recuperado el 25 de marzo de 2023, de https://manual.seen.es/article?id=55114d9d-06ec-40c9-8db5-44feac18103c
  • 10.1016/j.eprac.2022.07.005
  • 10.4067/S0034-98872020000300404
  • 10.1016/j.medcli.2014.10.016
  • 10.1001/jama.2019.22450
  • 10.1210/clinem/dgab852
  • 10.1002/ajh.26100
  • 10.1136/bmj.g4616
  • 10.1172/jci.insight.124486
  • De Medicamentos Y Productos Sanitarios, A. E. (s. f.). .:: CiMA ::. Ficha tecnica Ferinject 50 mg/ml solucion inyectable y para perfusion. https://cima.aemps.es/cima/dochtml/ft/69771/FichaTecnica_69771.html
  • 11. Inyector® [prospecto]. Shirley, NY, EE. UU.: American Regent, Inc., 2020.
  • Schaefer B, Tobiasch M, Wagner S, Glodny B, Tilg H, Wolf M, Zoller H. Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management. Bone. 2022 Jan;154:116202.
  • Blumenstein I, Shanbhag S, Langguth P, Kalra PA, Zoller H, Lim W. Newer formulations of intravenous iron: a review of their chemistry and key safety aspects - hypersensitivity, hypophosphatemia, and cardiovascular safety. Expert Opin Drug Saf. 2021 Jul;20(7):757-769.